Similarities between Major depressive disorder and Paroxetine
Major depressive disorder and Paroxetine have 18 things in common (in Unionpedia): Alpha-2 adrenergic receptor, Antidepressant, Bipolar disorder, Dysthymia, Epileptic seizure, Fluoxetine, Food and Drug Administration, Generalized anxiety disorder, Hypomania, Insomnia, Mania, Monoamine oxidase inhibitor, Neuroleptic malignant syndrome, Posttraumatic stress disorder, Selective serotonin reuptake inhibitor, Serotonin, Tryptophan, Venlafaxine.
Alpha-2 adrenergic receptor
The alpha-2 (α2) adrenergic receptor (or adrenoceptor) is a G protein-coupled receptor (GPCR) associated with the Gi heterotrimeric G-protein.
Alpha-2 adrenergic receptor and Major depressive disorder · Alpha-2 adrenergic receptor and Paroxetine ·
Antidepressant
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.
Antidepressant and Major depressive disorder · Antidepressant and Paroxetine ·
Bipolar disorder
Bipolar disorder, previously known as manic depression, is a mental disorder that causes periods of depression and periods of abnormally elevated mood.
Bipolar disorder and Major depressive disorder · Bipolar disorder and Paroxetine ·
Dysthymia
Dysthymia, now known as persistent depressive disorder (PDD), is a mood disorder consisting of the same cognitive and physical problems as depression, with less severe but longer-lasting symptoms.
Dysthymia and Major depressive disorder · Dysthymia and Paroxetine ·
Epileptic seizure
An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain.
Epileptic seizure and Major depressive disorder · Epileptic seizure and Paroxetine ·
Fluoxetine
Fluoxetine, also known by trade names Prozac and Sarafem, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
Fluoxetine and Major depressive disorder · Fluoxetine and Paroxetine ·
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Food and Drug Administration and Major depressive disorder · Food and Drug Administration and Paroxetine ·
Generalized anxiety disorder
Generalized anxiety disorder (GAD) is an anxiety disorder characterized by excessive, uncontrollable and often irrational worry, that is, apprehensive expectation about events or activities.
Generalized anxiety disorder and Major depressive disorder · Generalized anxiety disorder and Paroxetine ·
Hypomania
Hypomania (literally "under mania" or "less than mania") is a mood state characterized by persistent disinhibition and elevation (euphoria).
Hypomania and Major depressive disorder · Hypomania and Paroxetine ·
Insomnia
Insomnia, also known as sleeplessness, is a sleep disorder where people have trouble sleeping.
Insomnia and Major depressive disorder · Insomnia and Paroxetine ·
Mania
Mania, also known as manic syndrome, is a state of abnormally elevated arousal, affect, and energy level, or "a state of heightened overall activation with enhanced affective expression together with lability of affect." Although mania is often conceived as a "mirror image" to depression, the heightened mood can be either euphoric or irritable; indeed, as the mania intensifies, irritability can be more pronounced and result in violence, or anxiety.
Major depressive disorder and Mania · Mania and Paroxetine ·
Monoamine oxidase inhibitor
Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).
Major depressive disorder and Monoamine oxidase inhibitor · Monoamine oxidase inhibitor and Paroxetine ·
Neuroleptic malignant syndrome
Neuroleptic malignant syndrome (NMS) is a life-threatening reaction that occasionally occurs in response to neuroleptic or antipsychotic medication.
Major depressive disorder and Neuroleptic malignant syndrome · Neuroleptic malignant syndrome and Paroxetine ·
Posttraumatic stress disorder
Posttraumatic stress disorder (PTSD)Acceptable variants of this term exist; see the Terminology section in this article.
Major depressive disorder and Posttraumatic stress disorder · Paroxetine and Posttraumatic stress disorder ·
Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder and anxiety disorders.
Major depressive disorder and Selective serotonin reuptake inhibitor · Paroxetine and Selective serotonin reuptake inhibitor ·
Serotonin
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.
Major depressive disorder and Serotonin · Paroxetine and Serotonin ·
Tryptophan
Tryptophan (symbol Trp or W) is an α-amino acid that is used in the biosynthesis of proteins.
Major depressive disorder and Tryptophan · Paroxetine and Tryptophan ·
Venlafaxine
Venlafaxine, sold under the brand name Effexor among others, is an antidepressant of the selective serotonin-norepinephrine reuptake inhibitor (SNRI) class.
Major depressive disorder and Venlafaxine · Paroxetine and Venlafaxine ·
The list above answers the following questions
- What Major depressive disorder and Paroxetine have in common
- What are the similarities between Major depressive disorder and Paroxetine
Major depressive disorder and Paroxetine Comparison
Major depressive disorder has 278 relations, while Paroxetine has 102. As they have in common 18, the Jaccard index is 4.74% = 18 / (278 + 102).
References
This article shows the relationship between Major depressive disorder and Paroxetine. To access each article from which the information was extracted, please visit: